Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BAYER AG
09/20BAYER : Launches Study To Evaluate Nondiabetic Chronic Kidney Disease Treatment
MT
09/20BAYER : extends clinical development program for finerenone with Phase III study in patien..
PU
09/20Bayer Extends Clinical Development Program for Kerendia
CI
09/20BAYER AKTIENGESELLSCHAFT : Release -2-
DJ
09/20BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
09/20BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
DJ
09/17BAYER AG : Morgan Stanley maintains a Buy rating
MD
09/16BAYER : launches transparency register for scientific collaborations with external partner..
PU
09/16BAYER : Reports 'Sustained Clinical Benefit' From New Studies on Vitrakvi Cancer Drug
MT
09/16BAYER : Latest analyses of Vitrakvi (larotrectinib) reaffirm powerful efficacy and tolerab..
PU
09/15BAYER AG : Credit Suisse sticks Neutral
MD
09/14BAYER : Unit Co-Leads $15 Million Funding Round for US-Based Biotechnology Group
MT
09/14BAYER : Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Caval..
BU
09/13BAYER AKTIENGESELLSCHAFT : Release -2-
DJ
09/13BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
DJ
More most relevant news
All news about BAYER AG
06:16aPRESS RELEASE : Tele Columbus AG: New product portfolio and offers for autumn: PYUR confir..
DJ
09/20BAYER : Launches Study To Evaluate Nondiabetic Chronic Kidney Disease Treatment
MT
09/20BAYER : extends clinical development program for finerenone with Phase III study in patien..
PU
09/20PRESS RELEASE : Tele Columbus AG: M7 and PYUR extend partnership
DJ
09/20Bayer Extends Clinical Development Program for Kerendia
CI
09/20PRESS RELEASE : Pfizer and BioNTech Announce -3-
DJ
09/20WYLD : Signs Deal With Bayer Unit For Satellite System For Beehives
MT
09/20PRESS RELEASE : AiCuris starts pilot trial with proprietary immunomodulator AIC649, a uniq..
DJ
09/20BAYER AKTIENGESELLSCHAFT : Release -2-
DJ
09/20BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
More news
News in other languages on BAYER AG
08:46a7 ERKENNTNISSE über die DAX-Aufsichtsräte
06:16aTELE COLUMBUS AG : Neues Produktportfolio und Herbstangebote: PYUR bestätigt aktuell beste..
09/20FRANKFURT STOCK EXCHANGE : Le Dax trébuche pour sa première séance à 40 valeurs
09/20Bayer lance une étude pour évaluer un traitement de la néphropathie chronique non diabé..
09/20BAYER : lance une étude de phase III sur la finerénone
09/20BAYER : erweitert klinisches Entwicklungsprogramm von Finerenon um Phase-III-Studie bei Pa..
09/20TELE COLUMBUS AG : M7 und PYUR verlängern Partnerschaft
09/20Bayer erweitert klinisches Entwicklungsprogramm von Finerenon
09/20GlobeNewswire/Pfizer und BioNTech geben positive -4-
09/20BAYER AKTIENGESELLSCHAFT : -2-
More news
Analyst Recommendations on BAYER AG
09/17BAYER AG : Morgan Stanley maintains a Buy rating
MD
09/15BAYER AG : Credit Suisse sticks Neutral
MD
08/30BAYER AG : JP Morgan reaffirms its Buy rating
MD
08/17BAYER AG : Buy rating from Kepler Cheuvreux
MD
08/11BAYER AG : Deutsche Bank maintains a Buy rating
MD
More recommendations
Press releases
09/20BAYER : extends clinical development program for finerenone with Phase III study in patien..
PU
09/20BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
09/16BAYER : launches transparency register for scientific collaborations with external partner..
PU
09/16BAYER : Latest analyses of Vitrakvi (larotrectinib) reaffirm powerful efficacy and tolerab..
PU
09/14BAYER : Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Caval..
BU
More press releases
Upcoming event on BAYER AG
09/22/21